These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34825164)

  • 1. WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization.
    Stuurman AL; Sharan A; Jahagirdar S; Elango V; Riera-Montes M; Kashyap N; Biccler J; Poluru R; Arora N; Mathai M; Mangtani P; DeVlieger H; Anderson S; Whitaker B; Wong HL; Cutland C; Guillard Maure C;
    Vaccine X; 2021 Dec; 9():100123. PubMed ID: 34825164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries.
    Watson G; Dodd C; Munoz FM; Eckert LO; Jones CE; Buttery JP; Yildirim IB; Kachikis A; Heath PT; Schlaudecker EP; Bond NH; Santarcangelo PL; Wilcox CR; Bellamy K; Elmontser M; Sienas L; Simon R; Khalil A; Townsend R; Sturkenboom M; Black S
    Pediatr Infect Dis J; 2021 Dec; 40(12):1127-1134. PubMed ID: 34596623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions.
    Kochhar S; Clarke E; Izu A; Emmanuel Kekane-Mochwari K; Cutland CL
    Vaccine; 2019 May; 37(22):2967-2974. PubMed ID: 31014963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment.
    Stuurman AL; Riera M; Lamprianou S; Perez-Vilar S; Anderson SA; Mangtani P; Devlieger H; Verstraeten T; Zuber PLF; Guillard Maure C
    Vaccine; 2018 Oct; 36(45):6736-6743. PubMed ID: 30266486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric and neonatal outcomes in South Africa.
    Cutland CL; Sawry S; Fairlie L; Barnabas S; Frajzyngier V; Roux JL; Izu A; Kekane-Mochwari KE; Vika C; De Jager J; Munson S; Jongihlati B; Stark JH; Absalon J
    Vaccine; 2024 Feb; 42(6):1352-1362. PubMed ID: 38310014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of GAIA Case Definitions: Results and Lessons Learnt of a Hospital-Based Prospective Cohort Study in the Valencia Region (2019-2020).
    Carmona A; Latorre Tejerina M; Martínez Sebastián A; Dobreva D; Jurca CP; Huerta Barberá S; Bernat Montoya V; Aristoy Zabaleta M; Pineda Caplliure A; Mansilla Roig B; Navío Anaya M; Tosca-Segura R; Tortajada-Girbés M; Díez-Domingo J; Orrico-Sánchez A
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adverse pregnancy and birth outcomes using archival medical records before and during the first wave of the COVID-19 pandemic in Kinshasa, Democratic Republic of Congo: a facility-based, retrospective cohort study.
    Arena PJ; Dzogang C; Gadoth A; Nkamba DM; Hoff NA; Kampilu D; Beia M; Wong HL; Anderson SA; Kaba D; Rimoin AW
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):31. PubMed ID: 36647021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the feasibility of passive surveillance for maternal immunization safety utilizing archival medical records in Kinshasa, Democratic Republic of the Congo.
    Gadoth A; Mukadi Nkamba D; Arena PJ; Hoff NA; Dzogang C; Kampilu D; Beya M; Wong HL; Anderson SA; Kaba D; Rimoin AW
    Vaccine; 2022 Jun; 40(26):3605-3613. PubMed ID: 35570074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine safety surveillance in Kenya using GAIA standards: A feasibility assessment of existing national and subnational research and program systems.
    Izulla P; Wagai JN; Akelo V; Ombeva A; Okeri E; Onyango D; Omore R; Fuller S; Khagayi S; Were J; Anderson SA; Wong HL; Tippett Barr BA
    Vaccine; 2023 Sep; 41(39):5722-5729. PubMed ID: 37550143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing feasibility of resources at health facilities in Uganda to diagnose pregnancy and neonatal outcomes.
    Stark JH; Wool E; Tran L; Robinson E; Chemelski M; Weibel D; Huang WT; Kochhar S; Hardy JR; Bailey S; Galiwango E; Kajungu D
    Int Health; 2019 Mar; 11(2):128-135. PubMed ID: 30252056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy.
    Sharan A; Stuurman AL; Jahagirdar S; Elango V; Riera-Montes M; Kashyap NK; Biccler J; Poluru R; Arora NK; Mathai M; Mangtani P; Devlieger H; Anderson S; Whitaker B; Wong HL; Moran A; Maure CG;
    EClinicalMedicine; 2022 Aug; 50():101506. PubMed ID: 35770255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project.
    Sharan A; Jahagirdar S; Stuurman AL; Elango V; Riera-Montes M; Kumar Kashyap N; Kumar Arora N; Mathai M; Mangtani P; Devlieger H; Anderson S; Whitaker B; Wong HL; Cutland CL; Guillard Maure C;
    Vaccine X; 2022 Aug; 11():100160. PubMed ID: 35434599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date.
    Davies HG; Bowman C; Watson G; Dodd C; Jones CE; Munoz FM; Heath PT; Cutland CL; Le Doare K
    Int J Gynaecol Obstet; 2023 Jul; 162(1):29-38. PubMed ID: 37194339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Vergnano S; Buttery J; Cailes B; Chandrasekaran R; Chiappini E; Clark E; Cutland C; de Andrade SD; Esteves-Jaramillo A; Guinazu JR; Jones C; Kampmann B; King J; Kochhar S; Macdonald N; Mangili A; de Menezes Martins R; Velasco Muñoz C; Padula M; Muñoz FM; Oleske J; Sanicas M; Schlaudecker E; Spiegel H; Subelj M; Sukumaran L; Tagbo BN; Top KA; Tran D; Heath PT;
    Vaccine; 2016 Dec; 34(49):6038-6046. PubMed ID: 27491687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global alignment of immunization safety assessment in pregnancy - The GAIA project.
    Bonhoeffer J; Kochhar S; Hirschfeld S; Heath PT; Jones CE; Bauwens J; Honrado Á; Heininger U; Muñoz FM; Eckert L; Steinhoff M; Black S; Padula M; Sturkenboom M; Buttery J; Pless R; Zuber P;
    Vaccine; 2016 Dec; 34(49):5993-5997. PubMed ID: 27751641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites. Nested case-control analysis of the immunization-associated risk: A study protocol.
    Macías Saint-Gerons D; Castro JL; Colomar M; Rojas E; Sosa C; Ropero AM; Serruya SJ; Pastor D; Chiu M; Velandia-Gonzalez M; Abalos E; Durán P; Gomez Ponce de León R; Tomasso G; Mainero L; Rubino M; De Mucio B
    BMJ Open; 2024 Jan; 14(1):e073095. PubMed ID: 38286697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions.
    Munoz FM; Eckert LO; Katz MA; Lambach P; Ortiz JR; Bauwens J; Bonhoeffer J
    Vaccine; 2015 Nov; 33(47):6441-52. PubMed ID: 26387433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study.
    Alliance for Maternal and Newborn Health Improvement (AMANHI) mortality study group
    Lancet Glob Health; 2018 Dec; 6(12):e1297-e1308. PubMed ID: 30361107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review.
    Davies HG; Thorley EV; Al-Bahadili R; Sutton N; Burt J; Hookham L; Karampatsas K; Lambach P; Muñoz F; Cutland CL; Omer S; Le Doare K
    Vaccine X; 2024 Jun; 18():100464. PubMed ID: 38495929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.